
Last updated: 2026-10-17 09:07:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Iambic Therapeutics, Inc. (IAM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $23.57, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.15 to $25.00. This page covers its latest market performance, valuation, price trends and company information.
-- | |
$19.31 | |
$25.00 | |
$5.95 | |
$18.91 | |
2.68M | |
2.49M | |
-- | |
$25.00 | |
$16.15 | |
-- | |
-- |
Iambic Therapeutics, Inc. (IAM) last closed at $18.91 as of 2026-10-17 00:00:00, unchanged from the previous close of $18.91.
During the latest regular trading session, IAM traded between $5.95 and $25.00, with a volume of 2.68M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Iambic Therapeutics, Inc. (IAM) moved from $18.91 to $23.57, representing a gain of 24.62% ($4.66).
The stock traded between $16.15 and $25.00 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2.49 million shares, -- versus the previous seven-day period, indicating -- trading activity.
Position in Range: 83.8%
IAM is currently trading at $23.57, placing it 83.8% of the way from its 52-week low of $16.15 to its 52-week high of $25.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
| Exchange | NASDAQ |
Eligible investors can buy real shares of Iambic Therapeutics, Inc. (IAM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.